Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia

Journal of Refractive Surgery

Volumn 24, Issue 1, 2008, Pages

  Thornton, Ivey ^a,b   Xu, Meng ^a   Krueger, Ronald R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; MITOMYCIN C; MOXIFLOXACIN; PREDNISOLONE ACETATE;

COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORNEA OPACITY; CORNEAL HAZE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; LOW DRUG DOSE; MULTIVARIATE ANALYSIS; MYOPIA; OUTCOME ASSESSMENT; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STANDARD; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 38349097961     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081597x-20080101-13     Document Type: Conference Paper

References (27)

1. Carones F, Vigo L, Scandola E, Vacchini L. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg. 2002;28:2088-2095.
2. Chang SW. Early corneal edema following topical application of mitomycin C. J Cataract Refract Surg. 2004;30:1742-1750.
3. Torres RM, Merayo-Lloves J, Daya SM, Blanco-Mezquita JT, Espinosa M, Nozal MJ, Bernal JL, Bernal J. Presence of mitomycin-C in the anterior chamber after photorefractive keratectomy. J Cataract Refract Surg. 2006;32:67-71.
4. Morales AJ, Zadok D, Mora-Retana R, Martinez-Gama E, Robledo NE, Chayet AS. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol. 2006;142:400-404.
5. Perez-Santonja JJ, Sakla HF, Alio JL. Evaluation of endothelial cell changes 1 year after excimer laser in situ keratomileusis. Arch Ophthalmol. 1997;115:841-846.
6. de Benito-Llopis L, Teus M, Ortega M. Effect of mitomycin-C on the corneal endothelium during excimer laser surface ablation. J Cataract Refract Surg. 2007;33:1009-1013.
7. Pfister R. Permanent corneal edema resulting from the treatment of PTK corneal haze with mitomycin; a case report. Cornea. 2004;23:744-747.
8. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology. 1988;95:813-821.
9. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98:317-321.
10. Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, Talley AR, Speaker MG. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99:1647-1654.
11. Thornton IL, Puri A, Xu M, Krueger R. Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Am J Ophthalmol. 2007;144:673-681.
12. Netto MV, Mohan RR, Sinha S, Sharma A, Gupta PC, Wilson SE. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze and long-term keratocyte density. J Refract Surg. 2006;22:562-574.
13. Fantes FE, Hanna KD, Waring GO, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol. 1990;108:665-675.
14. Majmudar PA, Forstot SL, Dennis RF, Nirankari VS, Damiano RE, Brenart R, Epstein RJ. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology. 2000;107:89-94.
15. Gambato C, Ghirlando A, Moretto E, Busato F, Midena E. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology. 2005;112:208-219.
16. Argento C, Cosentino MJ, Ganly M. Comparison of laser epithelial keratomileusis with and without the use of mitomycin C. J Refract Surg. 2006;22:782-786.
17. Rajan MS, O'Brart DP, Patmore A, Marshall J. Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy. J Cataract Refract Surg. 2006;32:1741-1747.
18. Netto MV, Chalita MR, Krueger RR. Corneal haze following PRK with mitomycin C as a retreatment versus prophylactic use in the contralateral eye. J Refract Surg. 2007;23:96-98.
19. Qazi MA, Johnson TW, Pepose JS. Development of late-onset subepithelial corneal haze after laser-assisted subepithelial keratectomy with prophylactic intraoperative mitomycin-C. Case report and literature review. J Cataract Refract Surg. 2006;32:1573-1578.
20. Sadeghi HM, Seitz B, Hayashi S, LaBree L, McDonnell PJ. In vitro effects of mitomycin C on human keratocytes. J Refract Surg. 1998;14:534-540.
21. McDermott ML, Wang J, Shin DH. Mitomycin and the human corneal endothelium. Arch Ophthalmol. 1994;112:533-537.
22. Seiler T, Holschbach A, Derse M, Jean B, Genth U. Complications of myopic photorefractive keratectomy with the excimer laser. Ophthalmology. 1994;101:153-160.
23. Krueger RR, Talamo JH, McDonald MB, Varnell RJ, Wagoner MD, McDonnell PJ. Clinical analysis of excimer laser photorefractive keratectomy using a multiple zone technique for severe myopia. Am J Ophthalmol. 1995;119:263-274.
24. Moller-Pedersen T, Cavanagh HD, Petroll WM, Jester JV. Corneal haze development after PRK is regulated by volume of stromal tissue removal. Cornea. 1998;17:627-639.
25. Lin N, Yee SB, Mitra S, Chuang AZ, Yee RW. Prediction of corneal haze using an ablation depth/corneal thickness ratio after laser epithelial keratomileusis. J Refract Surg. 2004;20:797-802.
26. Vinciguerra P, Camesasca FI, Torres IM. Transition zone design and smoothing in custom laser-assisted subepithelial keratectomy. J Cataract Refract Surg. 2005;31:39-47.
27. Nassaralla BA, McLeod SD, Nassaralla JJ Jr. Prophylactic mitomycin C to inhibit corneal haze after photorefractive keratectomy for residual myopia following radial keratotomy. J Refract Surg. 2007;23:226-232.